Oral omega-3 fatty acid for reduction of kidney dysfunction induced by reperfusion injury in rats

Iranian Journal of Kidney Diseases

Volumn 6, Issue 4, 2012, Pages 275-283

  Ashtiyani, Saeed Changizi ^a   Najafi, Houshang ^b   Kabirinia, Kobra ^a   Vahedi, Ellham ^a   Jamebozorky, Leila ^a  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute kidney failure; Kidney function tests; Omega 3 fatty acid; Oxidative stress

Indexed keywords

CREATININE; MALONALDEHYDE; NITROGEN; OMEGA 3 FATTY ACID; POTASSIUM; SODIUM; UREA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; KIDNEY ISCHEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; POTASSIUM EXCRETION; RAT; REPERFUSION INJURY; SODIUM EXCRETION; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URINE FLOW RATE; URINE OSMOLALITY;

ACUTE KIDNEY INJURY; ADMINISTRATION, ORAL; ANIMALS; CREATININE; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; GLOMERULAR FILTRATION RATE; MALE; OSMOLAR CONCENTRATION; OXIDATIVE STRESS; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; RENAL AGENTS; REPERFUSION INJURY; SODIUM; UREA;

EID: 84864444819     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Clarkson MR, Friedewald JJ, Eustace JA, Rabb H. Acute kidney injury. In: Brenner BM, Livine SA, editors. Brenner and Rectore's the kidney. 8th ed. Philadelphia: WB Saunders; 2008. p. 943-86.
2. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. New Eng J Med. 1996;30:1448-59.
3. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflamatory disease?. Kidney Int. 2004;66:480-5.
4. Sutton TA, Fisher CJ, Molitoris BA. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int. 2002;62:1539-49.
5. Donadio JV. Omega-3 polyunsaturated fatty acids: A potential new treatment of immune renal disease. Mayo Clin Proc. 1991;66:1018-28.
6. Lands WEM. Biochemistry and physiology of n-3 fatty acids. FASEBJ. 1992;6:2530-6.
7. Kremer JM. n-3 fatty acid supplements in rheumatoid arthritis. Am J Clin Nutr. 2000;71:349S-51S.
8. Blok WL, Katan MB, Van Der Meer JW. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J Nutr. 1996;126:1515-33.
9. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21:495-505.
10. No author listed. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999;354:447-55.
11. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002;347:738-48.
12. Tomobe YI, Morizawa K, Tsuchida M, Hibino H, Nakano Y, Tanaka Y. Dietary docosahexaenoic acid suppresses inflammation and immunoresponses in contact hypersensitivity reaction in mice. Lipids. 2000;35:61-69.
13. De Caterina R, Liao JK, Libby P. Fatty acid modulation of endothelial activation. Am J of Clin Nutr. 2000;71(Suppl.):213S-23S.
14. Sabry A, El-Husseini A, Sheashaa H, et al. Colchicine vs. omega-3 fatty acids for prevention of chronic cyclosporine nephrotoxicity in sprague dawley rats: an experimental animal model. Arch Med Res. 2006;37:933-40.
15. Shi Y, Pestka J. Attenuation of mycotoxin-induced IgA nephropathy by eicosapentaenoic acid in the mouse: dose response and relation to IL-6 expression. J Nutr Biochem. 2006;17:697-706.
16. Jia Q, Zhou HR, Bennink M, Pestka JJ. Decosahexaenoic acid attenuates mycotoxin-induced immunoglobulin A nephropathy, interleukin-6 transcription, and mitogen-activated protein kinase phosphorylation in mice. J Nutr. 2004;134:3343-9.
17. Priyamvada S, Priyadarshini M, Arivarasu NA, et al. Studies on the protective effect of dietary fish oil on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney. Prostaglandins Leukot Essent Fatty Acids. 2008;78:369-81.
18. Zararsiz I, Sonmez MF, Yilmaz HR, et al. Effects of omega-3 essential fatty acids against formaldehyde-induced nephropathy in rats. Toxicol Ind Health. 2006;22:223-29.
19. Garman JH, Mulroney S, Manigrasso M, Flynn E, Maric C. Omega-3 fatty acid rich diet prevents diabetic renal disease. Am J Physiol Renal Physiol. 2008;296:F306-16.
20. An WS, Kim HJ, Cho KH, Vaziri ND. Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney. Am J Physiol Renal Physiol. 2009;297:F895-903.
21. Kielar ML, Jeyarajah DR, Zhou XJ, Lu CY. Docosahexaenoic acid ameliorates murine ischemic acute renal failure and prevents increases in mRNA abundance for both TNF-α and inducible nitric oxide synthase. J Am Soc Nephrol. 2003;14:389-96.
22. Neumayer H, Heinrich M, Schmissas M, Haller H, Wagner K, Luft FC. Amelioration of ischemic acute renal failure by dietary fish oil administration in conscious dogs. J Am Soc Nephrol. 1992;3:1312-20.
23. Hassan IR, Gronert K. Acute changes in dietary ω-3 and ω-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective decosahexaenoic acid-derived protectin D1. J Immunol. 2009;182:3223-32.
24. Bas O, Songur A, Sahin O, Mollaoglu H. The protective effect of fish n-3 fatty acids on cerebral ischemia in rat hippocampus. Neurochem Int. 2007;50:548-54.
25. Moosavi SMS, Ashtiyani SC, Hosseinkhani S, Shirazi M. Comparison of the effects of L-carnitine and tocopherol on acute ureteral obstruction-induced renal oxidative imbalance and altered energy metabolism in rats. Urol Res. 2010;38:187-94.
26. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-8.
27. Benzie IF, Strain JJ. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 1999;299:15-27.
28. Schwartz MM, Lan SP, Bernstein J, Hill GS, Holley K, Lewis EJ. Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. The lupus nephritis collaborative study group. Am J Kidney Dis. 1993;21:374-7.
29. Strenberg SS. Diagnostic surgical pathology. 3rd ed. Philadelphia: Lippincott: Williams & Wilkins;1996. p. 1701-85.
30. Moosavi S, Bayat G, Owji S, Panjehshahin M. Early renal post-ischaemic tissue damage and dysfunction with contribution of A1-adenosine receptor activation in rat. Nephrology. 2009;14:179-88.
31. Koppen BM, Stanton BA. Renal physiology. 4th ed. Mosby: Elesevier; 2007. p. 113-28.
32. Baek SM, Makabali GG, Brown RS, Shoemaker WC. Free-water clearance patterns as predictors and therapeutic guides in acute renal failure. Surgery. 1975;77:632-40.
33. Kwon TH, Frokiaer J, Fernández-Llama P, Knepper MA, Nielsen S. Reduced abundance of aquaporins in rats with bilateral ischemia-induced acute renal failure. Am J Physiol Renal Physiol. 1999;277:413-27.
34. Fernández-Llama P, Andrews P, Turner R, et al. Decreased abundance of collecting duct aquaporins in post-ischemic renal failure in rats. J Am Soc Nephrol. 1999;10:1658-68.
35. Padanilam BJ. Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis. Am J Physiol Renal Physiol. 2003;284:F608-27.
36. Duffield JS, Hong S, Vaidya VS, et al. Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol. 2006;177:5902-11.
37. Gronert K, Hassan IR. Reaping the benefits of renal protective lipid autacoids. Drug Discov Today Dis Mech. 2007;4:3-10.
38. Zhao Y, Joshi-Barve S, Barve S, Chen LH. Eicosapentaenoic acid prevents LPS-induced TNF-α Expression by preventing NF-kB activation. J Am Coll Nutr. 2004;23:71-78.
39. Lenardo MJ, Baltimore D. NF-B: A pleiotropic mediator of inducible and tissue specific gene control. Cell. 1989;58:227-9.
40. Xi S, Chen LH. Effects of dietary fish oil on tissue glutathione and antioxidant defense enzymes in mice with murine AIDS. Nutr Res. 2000;20:1287-99.
41. Schreck R, Albermann K, Baeuerle PA. Nuclear Factor-kB: An oxidative stress-responsive transcription factor of eukaryotic cells. Free Rad Res Comm. 1992;17:221-37.
42. Gius D, Botero A, Shah S, Curry HA. Intracellular oxidation/ reduction status in the regulation of transcription factors NF-kB and AP-1. Toxicol Letters. 1999;106:93-106.
43. Goncalves AR, Fujihara CK, Mattar AL, et al. Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-nflammatory. Am J Physiol Renal Physiol. 2004;286:F945-54.
44. Hao CM, Breyer MD. Physiologic and pathophysiologic roles of lipid mediators in the kidney. Kidney Int. 2007;71:1105-15.
45. De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb. 1994;14:1829-36.
46. Dwyer JH, Allayee H, Dwyer KM, et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med. 2004;350:29-37.